IQVIA Scribe vs TrialPal2
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
IQVIA Scribe
This application allows patients participating in clinical trials to securely capture and submit data directly from their mobile devices. It provides relevant questionnaires throughout the study duration, amplifying patient voices in research.
- Online/offline data capture
- Patient enrollment notifications
- Study-specific questionnaires
- Secure data submission
- Automated eCOA process
Read full descriptionHide full description
IQVIA Scribe is an online/offline application used to capture data directly from patients enrolled in clinical trials. Patients enrolled in a study using Scribe will receive an enrollment notification via email or text with a link to download the application and instructions used to enroll in the study. Relevant questionnaires will be available for completion throughout the duration of the study ++++Scribe amplifies the patient's voice in clinical research by allowing Clinical Outcomes Assessments to be used in more trials. Whether deploying to smartphones, tablets or the web, our Sculptor visual build and deployment tools help automate the eCOA process, giving absolute transparency and greater control to sponsors and CRO’s.
TrialPal2
Read full descriptionHide full description
To use this application it is necessary to have been previously invited to participate in a clinical study, since you must have a username and password. TrialPal is an appl that allows real-time reporting of possible symptoms associated with the application of a vaccine or the taking of any medication; It also allows the registration of the electronic diary and communication via chat with the site staff. The app allows you to know which are the reports that you must complete on a daily basis and allows you to manage the scheduling of the reports to be sent in the future. All the functionalities of the application are configured from the site according to the protocol of the project in which users are participating.
Screenshots
Verdict
The clearest difference is update cadence: TrialPal2 at monthly against IQVIA Scribe's every 2 months. On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
IQVIA Scribe ships an update every 2 months, TrialPal2 monthly. The most recent releases landed on October 26, 2026 and October 7, 2026 respectively.
| Parameter | IQVIA Scribe | TrialPal2 |
|---|---|---|
| Price | Free | Free |
| Rating | 3.0 (37 ratings) — better | — |
| Positive reviews | 20.0% of reviews | — |
| Number of ratings | 37 — better | — |
| Update frequency | Every 2 months | Monthly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.5 | 14.0 — better |
| Further details — not scored | ||
| Size | 32 MB | 29 MB |
| Age rating | 4+ | 12+ |
| Developer | IQVIA RDS INC. | INTEGRA IT SAS |
In-app purchases
IQVIA Scribe
No in-app purchases
TrialPal2
No in-app purchases






